(Q53383813)

English

High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma.

scientific article published on 15 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

1 reference

based on heuristic

inferred from title

author name string

Min Ho Park

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

Ji Shin Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

Jung Han Yoon

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

publication date

15 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

106

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

386-392

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

Cancer statistics in Korea: incidence, mortality and survival in 2006-2007.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

New trends in molecular biomarker discovery for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Cancer despite immunosurveillance: immunoselection and immunosubversion

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

New aspects of natural-killer-cell surveillance and therapy of cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

CD1a and antitumour immune response

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Chemokines: a new classification system and their role in immunity

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Chemokines in human breast tumor cells: modifying their expression levels and determining their effects on the malignancy phenotype

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Fractalkine and fractalkine receptors in human neurons and glial cells

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23095

21 January 2018

Identifiers

10.1002/JSO.23095

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22422195

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53383813&oldid=1790133620"